[1]姚 晴.布地格福吸入剂治疗慢阻肺的疗效及对CRP、SaO2的影响[J].医学信息,2024,37(20):80-83.[doi:10.3969/j.issn.1006-1959.2024.20.014]
　YAO Qing.Efficacy of Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol in the Treatment of Chronic Obstructive Pulmonary Disease and its Effect on CRP, SaO2 Levels[J].Journal of Medical Information,2024,37(20):80-83.[doi:10.3969/j.issn.1006-1959.2024.20.014]
点击复制

布地格福吸入剂治疗慢阻肺的疗效及对CRP、SaO2的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年20期
页码:
80-83
栏目:
论著
出版日期:
2024-10-15

文章信息/Info

Title:
Efficacy of Budesonide, Glycopyrronium Bromide and Formoterol Fumarate Inhalation Aerosol in the Treatment of Chronic Obstructive Pulmonary Disease and its Effect on CRP, SaO2 Levels
文章编号:
1006-1959（2024）20-0080-04
作者:
姚 晴
弋阳县人民医院呼吸与危重症医学科，江西 弋阳 334400
Author(s):
YAO Qing
Department of Respiratory and Critical Care Medicine,Yiyang County People’s Hospital,Yiyang 334400,Jiangxi,China
关键词:
布地格福吸入剂; 慢阻肺; C反应蛋白; 动脉血氧饱和度
Keywords:
Budesonide;  glycopyrronium bromide and formoterol fumarate inhalation aerosol; Chronic obstructive pulmonary disease; C-reactive protein; Arterial oxygen saturation
分类号:
R563
DOI:
10.3969/j.issn.1006-1959.2024.20.014
摘要:
目的 研究布地格福吸入剂治疗慢阻肺的疗效及对CRP、SaO2水平影响。方法 选取2019年4月-2023年5月我院诊治的98例慢阻肺患者为研究对象，采用随机数字表法分为对照组（n=49）和观察组（n=49）。对照组采用布地奈德福莫特罗粉吸入剂治疗，观察组采用布地格福吸入剂治疗，比较两组临床疗效、慢阻肺症状评分（CAT）、血清C反应蛋白（CRP）、动脉血氧饱和度（SaO2）、呼吸困难症状评分（SGRQ）、不良反应发生率。结果 观察组治疗总有效率为95.92%，高于对照组的81.63%（P＜0.05）；两组治疗后CAT评分、SGRQ评分、CRP低于治疗前，SaO2大于治疗前，且观察组CAT评分、SGRQ评分、CRP低于对照组，SaO2大于对照组（P＜0.05）；观察组不良反应发生率为6.12%，低于对照组的14.29%（P＜0.05）。结论 布地格福吸入剂治疗慢阻肺的临床疗效确切，可抑制炎症反应，改善血气指标，降低不良反应发生几率。
Abstract:
Objective To study the efficacy of budesonide, glycopyrronium bromide and formoterol fumarate inhalation aerosol in the treatment of chronic obstructive pulmonary disease and its effect on CRP and SaO2 levels.Methods A total of 98 patients with chronic obstructive pulmonary disease diagnosed and treated in our hospital from April 2019 to May 2023 were selected as the research objects. They were divided into control group (n=49) and observation group (n=49) by random number table method. The control group was treated with budesonide formoterol powder inhalation, and the observation group was treated with budesonide, glycopyrronium bromide and formoterol fumarate inhalation aerosol. The clinical efficacy, chronic obstructive pulmonary symptom score (CAT), serum C-reactive protein (CRP), arterial oxygen saturation (SaO2), dyspnea symptom score (SGRQ) and incidence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 95.92%, which was higher than 81.63% in the control group (P<0.05). After treatment, the CAT score, SGRQ score and CRP in the two groups were lower than those before treatment, SaO2 was higher than that before treatment, and the CAT score, SGRQ score and CRP in the observation group were lower than those in the control group, SaO2 was higher than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was 6.12%, which was lower than 14.29% in the control group (P<0.05).Conclusion The clinical efficacy of budesonide, glycopyrronium bromide and formoterol fumarate inhalation aerosol in the treatment of chronic obstructive pulmonary disease is definite, which can inhibit the inflammatory reaction, improve the blood gas index and reduce the incidence of adverse reactions.

参考文献/References:

[1]李斯南,朱述阳,罗涛,等.吸入激素联合噻托溴铵治疗哮喘-慢性阻塞性肺疾病重叠综合征的效果及对血清炎症因子水平的影响[J].临床和实验医学杂志,2019,18(16):1748-1751.[2]张华根,曾伟坚,彭贵霞,等.布地奈德福莫特罗粉吸入剂联合孟鲁司特钠在哮喘-慢阻肺重叠综合征患者治疗中的应用研究[J].实用药物与临床,2018,21(7):811-814.[3]柯勰,刘先胜.2014全球哮喘处理和预防策略解读[J].临床内科杂志,2018,31(12):863-864.[4]常秀群,肖志华.吸入激素噻托溴铵对哮喘-慢性阻塞性肺疾病重叠综合征的治疗效果分析[J].中国药物与临床,2019,19(8):113-114.[5]Calzetta L,Ritondo BL,de Marco P,et al.Evaluating triple ICS/LABA/LAMA therapies for COPD patients:a network meta analysis of ETHOS, KRONOS,IMPACT,and TRILOGY studies[J].Expert Rev Respir Med,2021,15(1):143-152.[6]黄绮芸,葛文逸,陈照娣,等.补中益气汤联合舒利迭治疗稳定期慢阻肺对患者mMRC及6MWT指标的影响[J].贵州医药,2022,46(7):1111－1112.[7]慢性阻塞性肺疾病急性加重(AECOPD) 诊治专家组.慢性阻塞性肺疾病急性加重( AECOPD) 诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.[8]翟雨婷,张建薇,许玲,等.弹力带抗阻运动联合呼吸功能训练治疗老年慢阻肺稳定期合并肌少症患者的临床分析[J].老年医学与保健,2022,28(2):291-295.[9]柴景伟,薛洪刚.布地格福与双联支气管扩张剂对慢性阻塞性肺疾病患者的疗效及肺功能与炎症因子的影响[J].中国药物经济学,2023,18(12):61-65.[10]王晋红,赵海,冯涛,等.基于气道黏液高分泌性探讨免疫调节剂联合布地格福治疗慢性阻塞性肺疾病效果及机制[J].疑难病杂志,2023,22(2):119-123,131.[11]章邱东,梅晓冬.布地格福吸入气雾剂治疗中、重度慢性阻塞性肺疾病患者的临床研究[J].中国临床药理学杂志,2022,38(3):203-206.[12]贾莉,雷蓉.布地格福气雾吸入剂与乌美溴铵维兰特罗吸入粉雾剂治疗重度COPD稳定期患者的疗效对比[J].贵州医药,2023,47(6):883-884.[13]葛南海,蔡孝桢,肖长长,等.肺康复联合无创通气对慢阻肺急性加重患者生活质量的影响[J].广东微量元素科学,2017,24(7):65-70.[14]Fang L,Gao P,Bao H,et al.Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J].Lancet Respir Med,2018,6(6):421-430.[15]李研,佟飞,米香.布地奈德福莫特罗粉吸入剂联合噻托溴铵粉吸入剂治疗ACOS的疗效及其对患者血清hs-CRP、EOS的影响[J].海南医学,2017,28(18):2997-3000.[16]卢健聪,邱惠中,陈丽丽.经鼻高流量氧疗与无创通气治疗慢性阻塞性肺疾病急性加重合并呼吸衰竭的效果比较[J].广东医学,2021,42(3):274-278.[17]舒冬冬,王晓静,徐晓梅,等.肺呼吸康复治疗在慢性阻塞性肺疾病稳定期患者中的应用研究[J].临床肺科杂志,2021,26(5):705-708.[18]徐琳琳,周瑞清,郑法德,等.糖皮质激素联合特布他林雾化吸入治疗慢性阻塞性肺疾病急性加重患者的临床疗效及其对肺功能的影响[J].实用心脑肺血管病杂志,2021,29(7):18-23.[19]张慧,陈国忠.补肺平喘方联合布地奈德福莫特罗粉吸入剂治疗慢性阻塞性肺疾病急性加重期(肺肾阳虚证)的疗效观察[J].中国中医急症,2021,30(4):710-713.[20]边明艳,卜丽.布地格福吸入气雾剂与布地奈德福莫特罗粉吸入剂对缓解期慢阻肺患者肺功能以及生活质量影响的对照研究[J].实用药物与临床,2022,25(1):42-45.

相似文献/References:

[1]黄朝宗.无创呼吸机对慢性阻塞性肺疾病急性加重患者治疗效果的影响[J].医学信息,2018,31(01):112.[doi:10.3969/j.issn.1006-1959.2018.01.042]
　HUANG Chao-zong.Effect of Noninvasive Ventilator on the Treatment of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(20):112.[doi:10.3969/j.issn.1006-1959.2018.01.042]
[2]温 蕾.复方异丙托溴铵常温雾化与加温雾化治疗 慢阻肺的护理效果分析[J].医学信息,2018,31(06):170.[doi:10.3969/j.issn.1006-1959.2018.06.061]
　WEN Lei.Analysis of Nursing Effect of Compound Ipratropium Bromide Nebulization at Room Temperature and Heating Atomization in Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(20):170.[doi:10.3969/j.issn.1006-1959.2018.06.061]
[3]王春艳,平玉卓,赵秀芹,等.协同护理干预对慢阻肺患者预后及自我护理能力的影响观察[J].医学信息,2018,31(13):181.[doi:10.3969/j.issn.1006-1959.2018.13.057]
　WANG Chun-yan,PING Yu-zhuo,ZHAO Xiu-qin,et al.Effect of Cooperative Nursing Intervention on Prognosis and Self-care Ability of Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(20):181.[doi:10.3969/j.issn.1006-1959.2018.13.057]
[4]鲁 婧,杜 君.肺心病左室舒张功能障碍发病机制的研究进展[J].医学信息,2019,32(04):54.[doi:10.3969/j.issn.1006-1959.2019.04.019]
　LU Jing,DU Jun.Advances in the Pathogenesis of Left Ventricular Diastolic Dysfunction in Pulmonary Heart Disease[J].Journal of Medical Information,2019,32(20):54.[doi:10.3969/j.issn.1006-1959.2019.04.019]
[5]周 笳,董丽霞.阿替普酶联合华法林治疗慢阻肺合并肺栓塞的有效性分析[J].医学信息,2019,32(05):146.[doi:10.3969/j.issn.1006-1959.2019.05.046]
　ZHOU Jia,DONG Li-xia.Efficacy Analysis of Alteplase Combined with Warfarin in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Embolism[J].Journal of Medical Information,2019,32(20):146.[doi:10.3969/j.issn.1006-1959.2019.05.046]
[6]刘伟娜.CD64感染指数、BODE指数与降钙素原在慢阻肺患者中的水平变化[J].医学信息,2019,32(06):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
　LIU Wei-na.Changes of CD64 Infection Index,BODE Index and Procalcitonin Levels in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2019,32(20):125.[doi:10.3969/j.issn.1006-1959.2019.06.039]
[7]钟红燕.盐酸氨溴索治疗慢阻肺合并肺部感染的临床效果[J].医学信息,2019,32(12):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
　ZHONG Hong-yan.Clinical Effect of Ambroxol Hydrochloride in the Treatment of Chronic Obstructive Pulmonary Disease with Pulmonary Infection[J].Journal of Medical Information,2019,32(20):154.[doi:10.3969/j.issn.1006-1959.2019.12.051]
[8]郑 新,张 颖.慢阻肺患者PSQI评分与NLR、PLR、CRP水平及急性加重频率的相关性[J].医学信息,2020,33(12):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
　ZHENG Xin,ZHANG Ying.Correlation of PSQI Score with NLR,PLR,CRP Level and Frequency of Acute Exacerbation in COPD Patients[J].Journal of Medical Information,2020,33(20):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
[9]田 芳.叙事护理对COPD患者负性情绪和呼吸症状群管理的效果[J].医学信息,2020,33(19):178.[doi:10.3969/j.issn.1006-1959.2020.19.058]
　TIAN Fang.The Effect of Narrative Nursing on the Management of Negative Emotion and Respiratory Symptoms in COPD Patients[J].Journal of Medical Information,2020,33(20):178.[doi:10.3969/j.issn.1006-1959.2020.19.058]
[10]李 婷.呼吸功能锻炼联合饮食护理干预对COPD生活质量的影响[J].医学信息,2021,34(01):188.[doi:10.3969/j.issn.1006-1959.2021.01.053]
　LI Ting.Effect of Respiratory Function Exercise Combined with Diet and Nursing Intervention on Life Quality of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2021,34(20):188.[doi:10.3969/j.issn.1006-1959.2021.01.053]

更新日期/Last Update: 1900-01-01